QQ客服 官方微博 反馈留言

	2-Aminopyrimidine Derivatives as New Selective Fibroblast Growth Factor Receptor 4 (FGFR4) Inhibitors
	Mo, Cheng[1,2]; Zhang, Zhang[3]; Guise, Christopher P.[4,5]; Li, Xueqiang[1,2]; Luo, Jinfeng[1]; Tu, Zhengchao[1]; Xu, Yong[1]; Patterson, Adam V.[4,5]; Smaill, Jeff B.[4,5]; Ren, Xiaomei[3]
	2017
卷号	8期号:5页码:543
URL标识	查看原文
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/4291247
专题	暨南大学
作者单位	1.[1]Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, State Key Lab Resp Dis, 190 Kaiyuan Ave, Guangzhou 510530, Guangdong, Peoples R China 2.[2]Univ Chinese Acad Sci, 19 Yuquan Rd, Beijing 100049, Peoples R China 3.[3]Jinan Univ, Sch Pharm, 601 Huangpu Ave West, Guangzhou 510632, Guangdong, Peoples R China 4.[4]Univ Auckland, Aucldand Canc Soc, Res Ctr, 92019 Private Bag, Auckland 1142, New Zealand 5.[5]Univ Auckland, Maurice Wilkins Ctr Mol Biodiscovery, 92019 Private Bag, Auckland 1142, New Zealand
推荐引用方式 GB/T 7714	Mo, Cheng[1,2],Zhang, Zhang[3],Guise, Christopher P.[4,5],et al. 2-Aminopyrimidine Derivatives as New Selective Fibroblast Growth Factor Receptor 4 (FGFR4) Inhibitors[J],2017,8(5):543.
APA	Mo, Cheng[1,2].,Zhang, Zhang[3].,Guise, Christopher P.[4,5].,Li, Xueqiang[1,2].,Luo, Jinfeng[1].,...&Ding, Ke[3].(2017).2-Aminopyrimidine Derivatives as New Selective Fibroblast Growth Factor Receptor 4 (FGFR4) Inhibitors.,8(5),543.
MLA	Mo, Cheng[1,2],et al."2-Aminopyrimidine Derivatives as New Selective Fibroblast Growth Factor Receptor 4 (FGFR4) Inhibitors".8.5(2017):543.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。